IONA Longitudinal Cohort Study

计划入组 10,000 人 · 首次发布于 2023 年 6 月 7 日

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

计划入组 240 人 · 首次发布于 2025 年 12 月 17 日

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

计划入组 660 人 · 首次发布于 2025 年 9 月 10 日

RONA-APOC3(Rona Therapeutics)

Purified Exosome Product (Rion)

ANGPTL3 siRNA(Rona Therapeutics)

Rion Inc.

South Korea

FUNDACION RIOJA SALUD

Spain

Viona Pharmaceuticals Inc.

United States

EMA Recommends Approval of Averoa's XOANACYL for Chronic Kidney Disease Treatment

Alzheimer's Researchers Urge Trial Participation Following Fiona Phillips' Diagnosis

Rinatabart Sesutecan Shows Promise in Heavily Pretreated Ovarian Cancer